Markets:

Overview

News

Currencies

International

Treasuries

Connect Biopharma Holdings Limited - Ordinary Shares (NQ:CNTB)

2.547 +0.027 (+1.06%)

Streaming Delayed Price Updated: 2:13 PM EDT, Apr 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Connect Biopharma Holdings Limited - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's After-Market Session ↗

October 27, 2023

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

October 02, 2023

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

September 22, 2023

Via Benzinga

Why Accolade Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

October 05, 2023

Gainers Orchard Therapeutics plc (NASDAQ: ORTX) shares climbed 97.7% to $15.98 after the company agreed to be acquired by Japan's Kyowa Kirin for $16.00 per ADS in cash plus an additional contingent...

Via Benzinga

Connect Biopharma Reports First Half 2023 Financial Results and Provides Business Update

September 12, 2023

From Connect Biopharma Holdings Limited

Via GlobeNewswire

Connect Biopharma Announces Receipt of NASDAQ Deficiency Notice Regarding Minimum Bid Price Requirement

September 12, 2023

From Connect Biopharma Holdings Limited

Via GlobeNewswire

Connect Biopharma to Participate in Upcoming September Investor Conferences

August 24, 2023

From Connect Biopharma Holdings Limited

Via GlobeNewswire

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 21, 2023

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 12, 2023

Via Benzinga

Connect Biopharma Presented Additional Data from its Atopic Dermatitis Pivotal Trial in China at the 2023 World Congress of Dermatology

July 10, 2023

From Connect Biopharma Holdings Limited

Via GlobeNewswire

Connect Biopharma to Participate in the SVB Securities Therapeutics Forum

July 05, 2023

From Connect Biopharma Holdings Limited

Via GlobeNewswire

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

June 05, 2023

It's time to start the week off right with a breakdown of the biggest pre-market stock movers worth watching on Monday morning!

Via InvestorPlace

Week In Review: Betta Pharma Enters $392 Million Deal For C4 Therapeutics’ NSCLC Drug ↗

June 03, 2023

Hangzhou Betta Pharma acquired greater China rights for a novel non-small cell lung cancer drug from Boston’s C4 Therapeutics in a deal worth up to $392 million. Additionally, Lynk Pharma of Hangzhou...

Via Talk Markets

Why Guidewire Software Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Friday's Mid-Day Session ↗

June 02, 2023

Gainers MultiMetaVerse Holdings Limited (NASDAQ: MMV) gained 236% to $3.1592 after the company announced it signed a non-binding term sheet to acquire an equity stake in Taomee group.

Via Benzinga

12 Health Care Stocks Moving In Friday's Pre-Market Session ↗

June 02, 2023

Via Benzinga

Why Lululemon Shares Are Trading Higher By 15%; Here Are 20 Stocks Moving Premarket ↗

June 02, 2023

Gainers Better Choice Company Inc. (NASDAQ: BTTR) shares rose 37% to $0.4522 in pre-market trading. Better Choice said it has selected Re:Amaze to assist in customer retention and acquisition for its...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday ↗

June 02, 2023

It's time for a dive into the biggest pre-market stock movers for Friday as we check out the winners and losers this morning!

Via InvestorPlace

12 Health Care Stocks Moving In Thursday's After-Market Session ↗

June 01, 2023

Via Benzinga

Connect Biopharma Announces Positive Long-Term Data from the Maintenance Period Through Week 48 of CN002 Phase 2 Icanbelimod Trial in Patients with Moderate-to-Severe Ulcerative Colitis

June 01, 2023

From Connect Biopharma Holdings Limited

Via GlobeNewswire

Connect Biopharma Reports Full Year 2022 Financial Results and Provides Business Update

April 11, 2023

From Connect Biopharma Holdings Limited

Via GlobeNewswire

Week In Review: HighlightLL Pharma Out-Licenses Parkinson's Treatment To Biohaven For $970 Million ↗

March 25, 2023

HighlightLL Pharma out-licensed rights to its novel oral, brain-penetrating, dual inhibitor to New Haven’s Biohaven in a deal worth up to $970 million. Biohaven will have global rights to the product...

Via Talk Markets

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

March 22, 2023

Via Benzinga

Why Citi Trends Shares Are Trading Lower By Over 14%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

March 21, 2023

Gainers U.S. Xpress Enterprises, Inc. (NYSE: USX) shares surged 298% to $5.97 after Knight-Swift Transportation agreed to acquire the company for $6.15 per share.

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

March 21, 2023

Via Benzinga

Why Cerberus Cyber Sentinel Shares Are Trading Higher By 147%; Here Are 20 Stocks Moving Premarket ↗

March 21, 2023

Gainers Cerberus Cyber Sentinel Corporation (NASDAQ: CISO) shares rose 147% to $0.5682 in pre-market trading. Cerberus Cyber Sentinel said it sees Q4 revenue of $14.7 million and sees FY22 revenue of...

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

March 21, 2023

We're starting off the day with a look at the biggest pre-market stock movers traders need to know about on Tuesday morning!

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

March 20, 2023

It's time to start off the trading week with a breakdown of the biggest pre-market stock movers for Monday and what's behind that movement!

Via InvestorPlace

Connect Biopharma's Atopic Dermatitis Candidate Shows Rapid, Sustained Improvement Across All Body Regions ↗

March 20, 2023

Connect Biopharma Holdings Limited (NASDAQ: CNTB) announced post hoc data analysis from the Phase 2b CBP-201 global trial in moderate-to-severe atopic dermatitis (AD).

Via Benzinga

Connect Biopharma CBP-201 Atopic Dermatitis China Pivotal Study Showed Rapid Relief of Patient Symptoms

March 18, 2023

From Connect Biopharma Holdings Limited

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.